KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Change in Acquisitions & Divestments (2016 - 2025)

Biomarin Pharmaceutical (BMRN) has disclosed Change in Acquisitions & Divestments for 17 consecutive years, with $43.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 72.02% year-over-year to $43.3 million, compared with a TTM value of $337.8 million through Dec 2025, down 46.64%, and an annual FY2025 reading of $337.8 million, down 46.64% over the prior year.
  • Change in Acquisitions & Divestments was $43.3 million for Q4 2025 at Biomarin Pharmaceutical, down from $98.8 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $275.9 million in Q2 2023 and bottomed at $43.3 million in Q4 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $157.3 million, with a median of $155.2 million recorded in 2022.
  • The sharpest move saw Change in Acquisitions & Divestments skyrocketed 105.53% in 2021, then crashed 72.02% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $188.9 million in 2021, then dropped by 24.45% to $142.8 million in 2022, then dropped by 20.71% to $113.2 million in 2023, then skyrocketed by 36.57% to $154.6 million in 2024, then plummeted by 72.02% to $43.3 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for BMRN at $43.3 million in Q4 2025, $98.8 million in Q3 2025, and $117.9 million in Q2 2025.